Navigation Links
Adeona Announces Second Quarter 2010 Profitability and Achievements
Date:8/16/2010

5 million upon filing of a New Drug Application with the Food and Drug Administration for flupirtine for fibromyalgia and $10 million upon marketing approval.
  • As of today, 97 out of 150 patients have been enrolled in the Trimesta clinical trial studying whether 8 mg of oral Trimesta taken daily over a 2 year period would reduce the rate of relapses in female relapsing-remitting multiple sclerosis patients. The randomized, double-blind, placebo-controlled clinical trial is currently underway at 16 centers in the United States. The clinical trial has received approximately $5.9 million in grant funding to date.

  • As of today, 54 out of 60 subjects have been enrolled in the Zinthionein clinical study testing the therapeutic effects of Adeona's proprietary oral, gastro-retentive, sustained-release zinc and cysteine formulation on cognition in Alzheimer's disease and mild cognitive impairment subjects. The randomized, double-blind, placebo-controlled study is currently underway at 3 centers in the United States. Study subjects are being assessed at 3 and 6 months for serum parameters of zinc and copper as well as changes in cognitive function using standard Alzheimer's disease clinical tests. Adeona expects completion of this clinical study in the first quarter of 2011.

  • HartLab, now renamed Adeona Clinical Laboratory, has added microbiology testing and pediatric testing services. The number of clients at the CLIA-certified diagnostic testing lab has doubled over the past few months. The lab is now open 7 days a week and offers walk-in phlebotomy services. Increased commercialization efforts are starting to result in increases in recurring revenues. Adeona Clinical Laboratory has been obtaining higher rates of reimbursement for the serum-based CopperProof Panel test.


    '/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Adeona Announces HartLab Expansion Into Microbiology Testing Services
2. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
(Date:5/21/2013)...  Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified ... of medical devices and in the domestic sale of diagnostic ... , President and CEO of Vasomedical, Inc. will present ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 9:30 a.m. EDT. ...
(Date:5/21/2013)... Calif. , May 21, 2013   ... announced today the publication of study results involving ... CyberKnife® Robotic Radiosurgery System, the most widely used ... The study followed 304 patients for a median ... post-treatment and found that 97 percent of patients ...
Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3
... THE WOODLANDS, Texas, Dec. 6, 2011 The US Oncology ... M.D., New York Oncology Hematology , and J. Russell ... discussion with oncologists on value-based reimbursement and its impact on the ... Dec. 13 at 1:00 p.m. ET/ 12 p.m. CT/ 11 a.m. ...
... and AMSTERDAM, Dec. 6, 2011 Agendia, an ... of formalin fixed, paraffin embedded tissue technology applied ... Delivering Agendia,s tests in a paraffin embedded tissue ... the superior science, development and validation found in ...
Cached Medicine Technology:The US Oncology Network to Present Webinar on Value-Based Reimbursement 2Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue 2
(Date:5/21/2013)... Antonio, TX (PRWEB) May 21, 2013 ... from the Texas Department of Aging and Disability Services. ... visits and employee interviews, ContinuCare Home Health was ... , The review is part of the Department of ... array of aging and disability services, supports and ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... Annual EB-5 Investment Summit: Dealmakers Conference in Long ... Conference will focus on exploring alternative finance through ... the latest market, legal and economic information, and ... and legal professionals within the EB-5 industry. ...
(Date:5/21/2013)... According to a May 13, 2013 New ... Botox,” Botox injections have become the most popular ... (Go to goo.gl/8iYbD). Although it is mostly associated with women, ... injection makes facial wrinkles less visible by paralyzing facial muscles. ... three months. This means that people who are conscious about ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to ... in the Creative Corridor region, is releasing results for ... conference on Thursday, May 23rd at 10:30 a.m. ... , The survey is a critical component ... that attract, nurture and retain people of diverse backgrounds, ...
(Date:5/21/2013)... A paper recently published in the New England ... scientists at the University of Colorado School of Medicine ... fibrosis can be used to identify individuals at risk ... a fairly common variant of the gene for mucin-5B, ... produced by the bronchial tubes. While this variant of ...
Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2
... experts say , TUESDAY, Dec. 29 (HealthDay News) -- Winter,s ... but they pose extra hazards for elderly people, experts say. ... adults over age 65 in the United States. Some 1.8 ... departments for falls in 2005, and 15,800 died from their ...
... , ... System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free cosmetic ... ... Health System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free ...
... YORK, Dec. 29 Nutritionist Judy Pentra, of Patients Medical , ... can be a vulnerable time for people trying to lose weight and ... holidays and many resolve to lose the weight in January, however, 70 ... of the biggest problems for busy executives trying to get in shape ...
... N.Y. -- The role of pharmacists hasn,t received much ... care. But national and regional studies show that when ... treatment costs and improve outcomes. A study on diabetic ... and Pharmaceutical Sciences identified cost savings with improvements in ...
... , Michigan Business and Professional Association ... Dec. 29 Eighty-three percent of the owners of small ... care plan as a public option for insurance, according to ... Business and Professional Association (MBPA) and the Michigan ...
... , , SAN JOSE, Calif. , ... 2009 a year of success in advocacy, research support and ... PF is a fatal disease that has no known cause, ... grassroots fundraising efforts in 2009, further advancing the effort to ...
Cached Medicine News:Health News:Caution Can Help Keep Elderly Safe During Winter 2Health News:Patients Medical Warns Against The Manhattan Diet 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 3Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 2Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 2Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 4
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: